Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





New AI-Driven Model for Predicting COVID-19 Impact Dramatically Outperforms Other Models

By HospiMedica International staff writers
Posted on 30 Nov 2020
A new model for predicting COVID-19's impact using artificial intelligence (AI) dramatically outperforms other models and has attracted the interest of public health officials across the US.

While existing models to predict the spread of a disease already exist, few, if any, incorporate AI, such as the one developed by scientists at the California Institute of Technology (Pasadena, CA, USA). More...
The use of AI allows a model to make predictions based on observations of what is actually happening - for example, increasing cases among specific populations - as opposed to what the model's designers think will happen. With the use of AI, it is possible to discover patterns hidden in data that humans alone might not recognize.

The researchers evaluate the accuracy of the new CS156 model (so-named for the Caltech computer science class where it got its start) by comparing it to the predictions of an ensemble model built by the Centers for Disease Control and Prevention from 45 major models from universities and institutes across the country. Using 1,500 predictions as points of comparison with the CDC ensemble, the researchers found that the CS156 model was more accurate than the ensemble model 58% of the time, as of November 25. It also routinely outperforms the benchmark projections of the Institute for Health Metrics and Evaluation (IHME).

The CS156 model is an amalgam of several models developed the team over the past nine months; the weight that each model has on the overall CS156 model's output is determined based on its performance over the previous weeks. The team is currently expanding the CS156 model based on feedback from public health officials in the hope that it can be a lifesaving tool to guide policy decisions. The team has been contacted by officials from the California Department of Public Health (CDPH) and from representatives of the New York City Commissioner of Health. Based on their feedback, the model is being modified to allow public health officials to predict how various interventions - like mask mandates and safer-at-home orders - affect control of the spread of the disease. Armed with those predictions, public health officials would be better able to evaluate which interventions are most likely to help. CDPH already uses the CS156 model in its decision-making.

"AI is a powerful tool, so it only makes sense to apply it to one of the most urgent problems the world faces," said Yaser Abu-Mostafa (PhD '83), professor of electrical engineering and computer science, who led the development of the new CS156 model. "All of us who are working on COVID-19 models are working toward the same goal: winning the war against the pandemic. We're here to do our part."

Related Links:
California Institute of Technology


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.